A 'one-two punch' against aggressive breast cancer could offer an alternative to chemotherapy

Triple-negative bosom crab (TNBC) has a frustrating quality to adapt. Although this assertive signifier of bosom crab tin initially respond good to chemotherapy, crab cells often find ways to survive, allowing the illness to instrumentality and go resistant to treatment.